Labshake search
Citations for Bio X Cell :
451 - 500 of 551 citations for MBL 2 Mouse HEK293 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... InVivoMab anti-mouse CD8 (BE0061) and InVivoMab rat IgG2b isotype control (BE0090) were purchased from Bioxcell (West Lebanon, NH).
-
bioRxiv - Immunology 2022Quote: ... The monolayer culture/epidermis was mechanically dissociated by rubbing through mesh into single-cell suspensions and then incubated with mouse Fc blocker (2.4G2, BioXCell) and the purified antibodies ...
-
bioRxiv - Immunology 2021Quote: ... Treated mice received combinations of 10mg/kg ZM 241385 injected intraperitoneally in 100μl vehicle and 100μg/mouse anti-TIM3 mAb (RMT3-23, BioXcell InVivoMAb) injected intraperitoneally in 100μl PBS on alternate days throughout the experiment ...
-
bioRxiv - Microbiology 2021Quote: ... NK and NKT cells were depleted using anti-NK1.1 depleting rat anti-mouse monoclonal antibody (clone PK136; BioXCell, USA). Hundred µg of the antibody or an IgG2a isotype control antibody (clone C1.18.4 ...
-
bioRxiv - Immunology 2019Quote: In vivo depletion of CD4+ T cells was achieved by administration of rat IgG2b anti-mouse CD4 (GK1.5, BioXCell). Control animals were treated with the matched isotype control antibody (LTF-2 ...
-
bioRxiv - Immunology 2022Quote: ... injections of 200μl of PBS containing or not rat anti-mouse PD-L1 monoclonal antibody (200μg/injection, clone 10F.9G2, BioXcell) were performed every three days between days 22 and 34 for a total of five injections ...
-
bioRxiv - Cancer Biology 2023Quote: ... SRC-3f/f and SRC-3d/d:Treg female mice were intraperitoneally treated with an anti-mouse Ifng antibody (BioXCell, catalog number ...
-
bioRxiv - Immunology 2024Quote: Immune checkpoint blockade protocol was performed by intravenous (i.v) injection of 200µg of anti-mouse PD-1 antibody (29F.1A12™ clone, BioXCell) and 200µg of anti-mouse CTLA-4 antibody (9H10 clone ...
-
bioRxiv - Immunology 2022Quote: ... The culture plates were pre-coated with 2 μg/mL anti-mCD3 (clone 145-2C11, Bio X Cell) and 2 μg/mL anti-mCD28 (clone 37.51 ...
-
bioRxiv - Immunology 2023Quote: CD4 T-cell depletion was accomplished via 2 intraperitoneal (i.p.) administrations of 200 µg of anti-CD4 (clone GK1.5; BE0003, BioXCell) one week and one day before challenge22 ...
-
bioRxiv - Cancer Biology 2023Quote: ... or isotype control antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone LTF2, BioXcell).
-
bioRxiv - Immunology 2024Quote: ... in the presence of soluble IL-2 and plate-bound anti-CD3 (5 μg/ml; 145-2C11; BioXcell)/anti-CD28 (2 μg/ml ...
-
bioRxiv - Immunology 2019Quote: 150 μg anti-IL-22 antibody (8E11, kindly provided by Genentech, South San Francisco, CA) or mouse IgG1 isotype control (MOPC-21, BioXCell) were administered i.p to Lgr5-GFP+/− mice every 2 days ...
-
bioRxiv - Cancer Biology 2020Quote: ... Anti-PDCA-1 (InVivoMAb anti-mouse CD317 Cat# BE0311) and IgG control (InVivoMAb anti-keyhole limpet hemocyanin Cat# BE0090) were purchased from BioXCell. Poly(I:C ...
-
bioRxiv - Immunology 2022Quote: ... and 5 weeks later injected with anti-CD4 monoclonal antibody (mAb, clone GK1.5, BioXCell, 500 μg /mouse, i.p. per injection) one day before secondary infection ...
-
bioRxiv - Immunology 2022Quote: ... and GPI-RBD-GM-CSF and GPI-IL-12 present in the lysates were purified using anti-mouse GM-CSF antibody (Clone MP1-22E9, BioXCell) and anti-mouse IL-12 antibody (clone C17.8 ...
-
bioRxiv - Cancer Biology 2020Quote: ... mice bearing MC38 tumours were treated with anti-mouse VEGFR2 antibody (clone DC101, 500 µg/dose, 27 mg/kg, BioXCell) injected intraperitoneally on the first and fourth day of imaging ...
-
bioRxiv - Cancer Biology 2021Quote: ... provided by Genentech)14 or anti-mouse VEGFR2 blocking antibody DC101 (40 mg/kg, on day 21 and 24 after the injection of cancer cells, BioXcell). For macrophage-depletion ...
-
The skin environment controls local dendritic cell differentiation and function through innate IL-13bioRxiv - Immunology 2021Quote: ... BM donor mice were depleted of T cells by intraperitoneal injection of 200 µg InVivoMAb anti-mouse Thy-1 (Clone T24/31, BioXCell) on day −5 and −2 before BM collection ...
-
bioRxiv - Cancer Biology 2022Quote: ... and anti-mouse PD-1 antibodies (clone RMP1-14, 10 mg/kg, 6 doses, every 3 days) were purchased from BioXcell. All drug treatments were administered intraperitoneally (i.p.).
-
bioRxiv - Immunology 2022Quote: ... which were infected and then treated three times with anti Thy1.1 (250ug/mouse i.p., Clone 19E12, BioXCell, West Lebanon, NH) every other day between days 56-60 p.i. ...
-
bioRxiv - Cell Biology 2023Quote: Pax7CreER/+/Rosa-YFP/CCR2RFP/+ mice were intraperitoneally treated with 250 μg anti-mouse ly6G antibody (clone 1A8, Bio X Cell) diluted in 150 μL saline 1 day before needle injury to deplete neutrophils in vivo ...
-
bioRxiv - Immunology 2022Quote: ... after which cells were stained with antibodies in autoMACS running buffer (Miltenyi) containing 5 ug/ml of anti-mouse CD16/32 (BioXcell) for 10 minutes at 4°C ...
-
bioRxiv - Immunology 2023Quote: ... three times per week) for 4 weeks and treated with 250 µg of mouse anti–IL-17a (clone 17F3, BioXcell) antibody intraperitoneally in a volume of 200 µL (diluted in PBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... we injected mice (i.p.) bearing MC38 tumors with 200 μg mouse IgG1 isotype control (clone MOPC-21; BioXCell; Cat #EB0083) or 200 μg mouse αIFNAR1 antibody (clone MAR1-5A3 ...
-
bioRxiv - Immunology 2023Quote: ... with 500μg (first dose) or 250μg (second and the following doses) of InVivoMAb anti-mouse IFNγ antibody (Clone: XMG1.2, Bio X Cell) or InVivoMAb rat IgG1 isotype control (Clone ...
-
bioRxiv - Neuroscience 2024Quote: ... we randomly assigned diabetic C57BL/6J mice to receive an intravenous injection of either 250 µg/mouse of IL-10R blocking antibody (BioXcell #BE0050 ...
-
bioRxiv - Immunology 2019Quote: ... CA); anti-human CD3ε (OKT3, BE0001-2; RRID:AB_1107632) and CD28 (9.3, BE0248; RRID:AB_2687729) from Bio X Cell (Lebanon, NH); anti-human TCR Vβ8 (C305 ...
-
bioRxiv - Immunology 2021Quote: ... mice were treated once with 2 mg of blocking antibodies one day prior to infection (Clone MAR1-5A3; BioXCell). Experiments involving SARS-CoV-2 infection were performed in a Biosafety Level 3 (BSL-3 ...
-
bioRxiv - Cell Biology 2022Quote: ... Isolated CD8+ T cells were stimulated for 2 days in 24 well culture plates coated overnight with 10μg/mL anti-CD3 antibody (clone 145-2C11, BioXCell) and 5μg/mL soluble anti-CD28 (clone 37.51 ...
-
bioRxiv - Immunology 2022Quote: ... and plated them on dishes coated with an antibodies for CD3 (2 μg/ml; clone 145-2C-11; BioXCell) and CD28 (1 μg/ml ...
-
bioRxiv - Immunology 2022Quote: ... 250 μg of a mix of anti-IL-2 neutralizing Abs (JES6-1A12 and S4B6-1; Bio X Cell), or 60,000U rIL-2 (National Cancer Institute ...
-
bioRxiv - Immunology 2023Quote: ... IL-2 signaling blockade was performed using a combination of JES61A12 and S4B6 anti-IL-2 antibodies at 200μg/ml (BioXCell) injected once daily through intraperitoneal route ...
-
bioRxiv - Cancer Biology 2023Quote: ... injection of either a-PD-L1 antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone 10F.9G2, BioXcell) or isotype control antibody (200μg twice weekly for 2 weeks ...
-
bioRxiv - Synthetic Biology 2023Quote: ... and were stimulated on plate-bound anti-CD3/CD28 for 1 day (2 μg/mL each, clones 145-2C11 and 37.51, respectively, BioXCell). Activated T cells were transduced on day 1 after stimulation using combinations of PEG-precipitated retroviral concentrates encoding different constructs adsorbed onto non-tissue culture treated 6-well plates coated with anti-CD3/CD28 2 μg/mL each and retronectin 20 μg/mL (Takara ...
-
bioRxiv - Immunology 2024Quote: ... The impact of CD8+ T cell depletions on SARS-CoV-2 infection was also evaluated using anti-CD8β (clone 53-5.8, BioXCell) and isotype mAb IgG2b (clone LTF-2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... followed by the treatment of vehicle or anti-PD-1 antibody (i.p., 200 μg/mouse, Bio X cell, clone RMP1-14) at day 0 ...
-
bioRxiv - Immunology 2020Quote: ... CD8 positive T cell depletion was achieved using 250 μg InVivoMab anti-mouse CD8α antibody (clone 53-6.7, BioXCell, BE0004-1) or IgG2a control (BioXCell ...
-
bioRxiv - Immunology 2020Quote: ... 50 μg/mouse) and their respective isotype controls rat IgG2a (2A3) and rat IgG1 (HRPN) were purchased from Bio X Cell.
-
bioRxiv - Immunology 2022Quote: ... Cells from each tissue were resuspended in PBS supplemented with 0.5% BSA and 1 mM EDTA and incubated first with FC-block (rat anti-mouse CD16/32, clone 2.4G2, Bio X Cell) for 30 min on ice and subsequently with various fluorescently-labeled antibodies (see Table S1 ...
-
bioRxiv - Cancer Biology 2022Quote: Antibodies used for in vivo treatment and blocking and for in vitro phagocytosis are as follows: anti-mouse/human Tyrp1 clone TA99 (BioXCell BE0151), mouse IgG2a isotype control clone C1.18.4 (BioXCell BE0085 ...
-
bioRxiv - Neuroscience 2023Quote: ... immunosuppression consisted of monoclonal antibodies against mouse CD4 (clone GK1.5, rat IgG2b,κ; catalog # BE0003-1, Bio X Cell, Lebanon, NH) and CD40L (clone MR-1 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were resuspended in PBS supplemented with 0.5% BSA and 1 mM EDTA and incubated first with Fc-block (rat anti-mouse CD16/32, clone 2.4G2, Bio X Cell) for 30 min on ice and subsequently with various fluorescently-labeled antibodies (see Supplementary Table 1 ...
-
bioRxiv - Immunology 2024Quote: ... injection of 50 μg anti-mouse CD20 (clone 5D2, a generous gift from Genentech) or IgG2a isotype control (Bio X Cell) in 100 μL PBS by tail vein ...
-
bioRxiv - Cancer Biology 2024Quote: Antibodies used for in vivo treatment and blocking and for in vitro phagocytosis are as follows: anti-mouse/human Tyrp1 clone TA99 (BioXCell BE0151), mouse IgG2a isotype control clone C1.18.4 (BioXCell BE0085) ...
-
bioRxiv - Immunology 2019Quote: ... rat IgG2b, LTF-2) and anti-Gr1 mAb (rat IgG2b, RB6-8C5) were purchased from BioXcell (West Lebanon, NH, USA). The MT807R1 recombinant Ig consisting of rhesus IgG1k constant regions and CDRs derived from the anti-human CD8 antibody M-T807 grafted into rhesus variable framework regions and was provided by the Nonhuman Primate Reagent Resource (NIH contract HHSN272200900037C and grant RR016001) ...
-
bioRxiv - Cancer Biology 2019Quote: ... Control mice were injected with an equivalent amount of rat IgG2b isotype control (Clone LTF-2, Bio X Cell, BE0090). Mice were euthanized 3 days post Myc inactivation and pancreata harvested for histological analysis.
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Microbiology 2023Quote: ... Control mice were injected with a similar dose of an isotype control antibody (#BE0090, Clone LTF-2, Bio X Cell). The mice were sacrificed after 1 ...
-
bioRxiv - Microbiology 2022Quote: ... Each mouse received 200 μg of GK1.5, 100 μg 116-13.1 or 200 μg isotype (LTF-2, rat IgG2b) control antibody (BioxCell, CAT# BE0090) in a volume of 200 μl PBS 9 days prior to the first vaccination ...